Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1992-07-21
1993-08-17
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303895, 424 858, A61K 3516, A61K 39395
Patent
active
052370534
ABSTRACT:
Preparations active against Pseudomonas aeruginosa infections, namely vaccines for active immunization as well as preparations containing antibodies and destined for passive protection; as well as methods for the production thereof.
The vaccines contain protective flagellar (H) antigens of the serotype a and b, which consist of monomeric components, each monomeric component is composed of certain amino acids having a certain N-terminal amino acid sequence and has a certain molecular weight. The vaccines are made from purified flagellar (H) antigen solutions. The immunoglobulin-G-containing preparations contain flagellar (H) antibodies obtained from the blood plasma of human donors or mammals immunized with protective flagellar (H) antigens. They can be purified by methods of affinity chromatography.
REFERENCES:
patent: 3674863 (1972-07-01), Fisher et al.
patent: 3928565 (1975-12-01), Homma et al.
patent: 3983229 (1976-09-01), Relyveld
patent: 3987164 (1976-10-01), Homma et al.
patent: 4075321 (1978-02-01), Relyveld
patent: 4079126 (1978-03-01), Homma et al.
patent: 4298597 (1981-11-01), Acres et al.
patent: 4402939 (1983-09-01), Fournier
patent: 4693891 (1987-09-01), Collins et al.
patent: 4702910 (1987-10-01), Fukuda et al.
patent: 4774086 (1988-09-01), Quentin-Miller et al.
patent: 4831121 (1989-05-01), Montie et al.
patent: 4946677 (1990-08-01), Dorner et al.
Holder et al-Flagellar Prep. from Ps aeruginosa:Animal Protection Studies (Infection and Immumity vol. 35; 276-280 1982 Jan.).
Montie, et al., "Flagellar Preparations from Psuedomas aeruginosa Isolation and Characterization", Infec. Immun. 35: 281-88 (1982).
Ansorg, et al., "Differentiation of the Major Flagellar Antigens of Pseudomonas aeruginosa by the Slide Coagglutination Technique", J. Clin. Microbiol. 20: 84-88 (1984).
Ansorg, "Flagella Specific H Antigenic Schema of Pseudomonas aeruginosa" , Zbl. Bakt. Hyg., I. Abt. Orig. A, vol. 242 (1978), pp. 228-238.
Ansorg, et al., "Immunological and Electrophoretic Characterization of Flagellins of Different H-Types of Pseudomonas aeruginosa", Medical Microbiology and Immunmology, vol. 168 (1980), pp. 217-226.
Fahey, et al., "Ion exchange chromatography and gel filtration", Handbook of Experimental Immunology, Third Edition, Chapter 7, pp. 8.1-8.16.
Heide, et al., "Salt fractionation of immunoglobulins", Handbook of Experimental Immunology, Third Edition, Chapter 7, pp. 7.1-7.11.
Montie, et al., "Loss of Virulence Associated with Absence of Flagellum in an Isogenic Mutant of Pseudomonas aeruginosa in the Burned-Mouse Model", Infection and Immunity, vol. 38, No. 3 (Dec. 1982), pp. 1296-1298.
Anderson, et al., "Opsonophagocytosis of Pseudomonas aeruginosa Treated with Antiflagellar Serum", Infection and Immunity, vol. 55, No. 12 (Dec. 1987), pp. 3204-3206.
Ansorg, et al., "Differentiation of the Major Flagellar Antigens of Pseudomonas aeruginosa by the Slide Coagglutination Technique", Journal of Clinical Microbiology, vol. 20, No. 1, (Jul. 1984), pp. 84-88.
Freeman, "Pseudomonas and Legionella", Burrows Textbook of Microbiology, Chapter 25, Twenty-Second Edition, pp. 544-549.
Holder, et al., "Flagellar Preparations from Pseudomonas aeruginosa: Animal Protection Studies", Infection and Immunity, vol. 35, No. 1 (Jan. 1982), pp. 276-280.
Jolles, et al., "The Practical Uses of Adjuvants", Chemical and Biological Basis of Adjuvants (1973), pp. 114-118.
Allison, et al., "Electrophoretic Separation and Molecular Weight Characterization of Pseudomonas aeruginosa H-Antigen Flagellins", Infection and Immunity, vol. 49, No. 3 (Sep. 1985), pp. 770-774.
Coatest.RTM. Endotoxin Manual Method, pp. 1-13.
Stieritz, et al., J. Infect. Dis., vol. 131 (1975), pp. 688-691.
Cryz, et al., "Passive Protection Against Pseudomonas aeruginosa Infection in an Experimental Leukopenic Mouse Model", Infection and Immunity, vol. 40, No. 2 (May 1983), pp. 659-664.
Holder et al., Abstracts of the Annual Meeting of the American Society for Microbiology 85: 12 No. A69 (1985).
Drake et al., Abstracts of the Annual Meeting of the American Society for Microbiology 85: 42 No. B143 (1985).
Montie et al., Abstracts of the Annual Meeting of the American Society for Microbiology 81: 17 No. B17 (1981).
Verall et al., Discovery and Isolation of Microbial Products 81-82 (1985).
Tramont, Adhesion of Neisseria Gonorrhoeae and Disease, in Adhesion and Microorganism Pathogenicity, 188, 199-200 (1981).
Ansorg et al., Zbl, Bakt. Hyg. 1, Abt. Orig. A 246: 363 (1980)* considered the English Abstract, document in German.
Dorner Friedrich
Eibl Johann
Immuno Aktiengesellschaft
Nucker Christine M.
Sidberry Hazel F.
LandOfFree
Preparation active against Pseudomonas aeruginosa infections and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation active against Pseudomonas aeruginosa infections and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation active against Pseudomonas aeruginosa infections and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2245133